We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Penlon Completes Sale of Medical Gas Business

By HospiMedica International staff writers
Posted on 31 Aug 2011
Penlon (Abingdon, United Kingdom) has successfully completed the divestment of its medical gas business, which has been acquired by Atlas Copco (Stockholm, Sweden) for an undisclosed purchase price.

The divestment is in line with Penlon’s strategy of focusing on its core business of anesthesia, and combined with Penlon’s global presence is expected to help drive growth opportunities, especially in international markets. More...
The divested division will become part of Atlas Copco’s Industrial Air division and the products will be sold under the brand name Penlon Medical Gas Solutions. The Atlas Copco Group already has a presence in the medical gas market through BeaconMedaes (Rock Hill, SC, USA), which specializes in medical gas systems. With the acquisition of Penlon Medical Gas Solutions, Atlas Copco intends to improve its global footprint and be a comprehensive solutions provider to worldwide medical gas customers.

“The medical gas market is a growing segment worldwide and has an aftermarket business with a good potential,” said Stephan Kuhn, business area president at Atlas Copco. “This acquisition supports Atlas Copco’s strategy of extending our medical gas offering globally and increasing revenues through aftermarket.”

“As a global player in anesthesia, this represents an important milestone for Penlon in our strategy to accelerate growth in our core business,” said Stephen Moon, CEO of Penlon. “The Penlon brand already has a strong heritage and we will look to further enhancing and strengthening our market position, underpinned by the talent and expertise of our global team.”

Related Links:

Penlon
Atlas Copco
BeaconMedaes



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.